JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1993) 11 129-139    DOI: 10.1677/jme.0.0110129
© 1993 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delhase, M
Right arrow Articles by Hooghe-Peters, E L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delhase, M
Right arrow Articles by Hooghe-Peters, E L

Pit-1/GHF-1 expression in pituitary adenomas: further analogy between human adenomas and rat SMtTW tumours

M Delhase, P Vergani, A Malur, B Velkeniers, E Teugels, J Trouillas and E L Hooghe-Peters

Adenomas can develop from each cell type of the anterior pituitary. In the normal pituitary, three of these cell types, the GH-, prolactin- and TSH-secreting cells, express the transcription factor Pit-1/GHF-1 which is responsible for prolactin and GH (and probably TSH) cell commitment, differentiation, probably proliferation and gene expression. We have analysed the expression of Pit-1/GHF-1 in a panel of human pituitary adenomas. All GH-, prolactin- and TSH-expressing adenomas studied expressed the Pit-1/GHF-1 factor, as demonstrated by in-situ hybridization and immunocytochemistry. The expression was higher in adenomas than in normal human pituitary. In contrast, ACTH- and LH—FSH-secreting and non-secreting adenomas were negative. Seven transplants of the spontaneous rat prolactinoma SMtTW were also investigated and all were found to be positive.

This further stresses the analogy between these tumours and human prolactinomas. Taken together, the data confirm that Pit-1/GHF-1 expression is restricted to GH-, prolactin- and TSH-expressing cells, and the increased expression in adenomas is compatible with a role of Pit-1/GHF-1 in cell proliferation.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
I. Pellegrini, C. Roche, M.-H. Quentien, M. Ferrand, G. Gunz, S. Thirion, C. Bagnis, A. Enjalbert, and J.-L. Franc
Involvement of the Pituitary-Specific Transcription Factor Pit-1 in Somatolactotrope Cell Growth and Death: An Approach Using Dominant-Negative Pit-1 Mutants
Mol. Endocrinol., December 1, 2006; 20(12): 3212 - 3227.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Seoane and R. Perez-Fernandez
The Vitamin D Receptor Represses Transcription of the Pituitary Transcription Factor Pit-1 Gene without Involvement of the Retinoid X Receptor
Mol. Endocrinol., April 1, 2006; 20(4): 735 - 748.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C Gil-Puig, S Seoane, M Blanco, M Macia, T Garcia-Caballero, C Segura, and R Perez-Fernandez
Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation
Eur. J. Endocrinol., August 1, 2005; 153(2): 335 - 344.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Society for Endocrinology.